Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle

BACKGROUND: Cancer is considered the second leading cause of death in the world, and for the treatment of this disease, pharmacological intervention strategies are frequently based on chemotherapy. Doxorubicin (DOX) is one of the most widely used chemotherapeutic agents in clinical practice for trea...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cachexia Sarcopenia Muscle
Egile Nagusiak: de Lima Junior, Edson Alves, Yamashita, Alex Shimura, Pimentel, Gustavo Duarte, De Sousa, Luís G. O., Santos, Ronaldo Vagner T, Gonçalves, Cinara Ludvig, Streck, Emilio Luiz, de Lira, Fábio Santos, Rosa Neto, Jose Cesar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2016
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4863825/
https://ncbi.nlm.nih.gov/pubmed/27239415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12104
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak